These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement. Tan L; Bansal G; Yeung CC; Yin J; Dave BJ; Konnick E; Wu D; Naresh KN Ann Hematol; 2024 Feb; 103(2):667-669. PubMed ID: 37882866 [No Abstract] [Full Text] [Related]
26. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features. Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622 [TBL] [Abstract][Full Text] [Related]
27. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233 [TBL] [Abstract][Full Text] [Related]
28. Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements. Juskevicius D; Ruiz C; Dirnhofer S; Tzankov A Am J Surg Pathol; 2014 May; 38(5):719-27. PubMed ID: 24722063 [TBL] [Abstract][Full Text] [Related]
29. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438 [TBL] [Abstract][Full Text] [Related]
30. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256 [TBL] [Abstract][Full Text] [Related]
31. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648 [TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological and molecular genetic features of cyclin D1-negative mantle cell lymphoma]. Wang GN; Zhang L; Li CF; Zhao WG; Zhang DD; Zhang YP; Li WC Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):296-300. PubMed ID: 35359039 [No Abstract] [Full Text] [Related]
33. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493 [TBL] [Abstract][Full Text] [Related]
34. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma. Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823 [TBL] [Abstract][Full Text] [Related]
35. Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines. Tiemann K; Alluin JV; Honegger A; Chomchan P; Gaur S; Yun Y; Forman SJ; Rossi JJ; Chen RW Leuk Lymphoma; 2011 Nov; 52(11):2148-54. PubMed ID: 21745168 [TBL] [Abstract][Full Text] [Related]
36. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma. Özoğul E; Montaner A; Pol M; Frigola G; Balagué O; Syrykh C; Bousquets-Muñoz P; Royo R; Fontaine J; Traverse-Glehen A; Bühler MM; Giudici L; Roncador M; Zenz T; Carras S; Valmary-Degano S; de Leval L; Bosch-Schips J; Climent F; Salmeron-Villalobos J; Bashiri M; Ruiz-Gaspà S; Costa D; Beà S; Salaverria I; Giné E; Quintanilla-Martinez L; Brousset P; Raffeld M; Jaffe ES; Puente XS; López C; Nadeu F; Campo E Blood Cancer J; 2024 Sep; 14(1):166. PubMed ID: 39313500 [TBL] [Abstract][Full Text] [Related]
37. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256 [TBL] [Abstract][Full Text] [Related]
38. Utility and diagnostic pitfalls of SOX11 monoclonal antibodies in mantle cell lymphoma and other lymphoproliferative disorders. Nakashima MO; Durkin L; Bodo J; Lin J; Quintanilla-Martinez L; Fu K; Hsi ED Appl Immunohistochem Mol Morphol; 2014; 22(10):720-7. PubMed ID: 25229384 [TBL] [Abstract][Full Text] [Related]
39. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management. Isaac KM; Portell CA; Williams ME Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910 [TBL] [Abstract][Full Text] [Related]
40. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]